Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb

Gutscheinbedingungen

*Gültig bis 05.07.2026 auf (fast) alles. Ausgeschlossen sind Smartboxen, Zeitschriften, Tickets, Lebensmittel, Gaming-Elektroartikel, Tinte/Toner, Gutscheine, Geschenkkarten, Blumen und Abos | Einlösbar in allen Buchhandlungen von Orell Füssli, Barth Bücher, Buchladen Rapunzel, Papeterie Köhler, Schuler Orell Füssli, Stauffacher und ZAP unter Vorweisung des Gutscheins, auf www.orellfüssli.ch durch Eingabe des Gutscheincodes. Beim Service „eBooks verschenken“ und bei eBook-Käufen via eReader nicht einlösbar | Mindesteinkaufswert: Fr. 30.- | Nicht mit anderen Rabatten kumulierbar.
Produktbild: Interventional Pericardiology

Interventional Pericardiology Pericardiocentesis, Pericardioscopy, Pericardial Biopsy, Balloon Pericardiotomy, and Intrapericardial Therapy

Fr. 143.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Set mit diversen Artikeln

Erscheinungsdatum

24.03.2011

Verlag

Springer Berlin

Seitenzahl

184

Maße (L/B/H)

24.5/17.2/1 cm

Gewicht

428 g

Auflage

2011

Sprache

Englisch

ISBN

978-3-642-11334-5

Beschreibung

Produktdetails

Einband

Set mit diversen Artikeln

Erscheinungsdatum

24.03.2011

Verlag

Springer Berlin

Seitenzahl

184

Maße (L/B/H)

24.5/17.2/1 cm

Gewicht

428 g

Auflage

2011

Sprache

Englisch

ISBN

978-3-642-11334-5

Herstelleradresse

Springer Nature Customer Service Center GmbH
Europaplatz 3
69115 Heidelberg
DE
ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Interventional Pericardiology
  • Foreword
    Preface
    Acknowledgments
    Authors
    1. A Historical Perspective
    1.1. Introduction
    1.2. Diagnostic and therapeutic pericardial interventions
    1.2.1. Pericardiocentesis and pericardial drainage
    1.2.2. Pericardioscopy
    1.2.3. Pericardial biopsy
    1.2.4. Percutaneous balloon pericardiotomy
    1.2.5. Intrapericardial treatment of pericardial disease
    1.2.6. Intrapericardial treatment of non-pericardial disease
    1.3. Future perspectives and recommendations
    2. Anatomy of the Pericardium Relevant for Pericardial Access, Pericardioscopy, and Intrapericardial Interventions
    2.1. Introduction
    2.2. Structures of the normal pericardium
    2.2.1. Pericardial sinuses and recesses
    2.2.2. Epicardial and pericardial fat
    2.2.3. Normal pericardial fluid
    2.2.4. Nerves, arteries, lymphatics, and lymph nodes
    2.3. Pericardial anomalies
    2.4. Distinction between the human and animal pericardium
    2.5. Future perspectives and recommendations
    3. Pericardial Effusion and Cardiac Tamponade
    3.1. Introduction
    3.2. Clinical presentation of cardiac tamponade
    3.3. Physical findings in cardiac tamponade
    3.3.1. Pulsus paradoxus
    3.4. Electrocardiogram in cardiac tamponade
    3.5. Chest radiography
    3.6. Echocardiography
    3.7. Cardiac catheterization and invasive hemodynamics
    3.8. Medical management of cardiac tamponade
    3.9. Future perspectives and recommendations
    4. Pericardial Access and Drainage: Standard Techniques
    4.1. Introduction
    4.2. Indications for pericardial drainage
    4.3. Emergency pericardiocentesis
    4.4. Echocardiography-guided pericardiocentesis
    4.4.1. Evolution of echo-guided pericardiocentesis
    4.4.2. Safety and efficacy of echo-guided pericardiocentesis
    4.4.3. Reduction of effusion recurrence with catheter drainage
    4.4.4. Technique of state-of–the-art echo-guided pericardiocentesis
    4.5. Pericardiocentesis guided by fluoroscopy
    4.5.1. Feasibility of fluroscopy guided pericardiocentesis
    4.5.2. The role of cardiac catheterization during pericardiocentesis
    4.5.3. Safety of fluoroscopy guided pericardiocentesis
    4.6. Surgical drainage of the pericardium
    4.7. Future perspectives and recommendations
    5. Alternative Techniques for Pericardiocentesis
    5.1. Introduction
    5.2. Pericardiocentesis guided by epicardial halo phenomenon
    5.2.1. Physical origin of the sign
    5.2.2. Tangential approach to the pericardial surface
    5.2.3. Feasibility and safety
    5.2.4. Clinical implications
    5.3. PerDUCER® technique
    5.3.1. Endoscopic guidance in patients with perimyocarditis
    5.3.2. PerDUCER® procedure in patients with moderate/large effusions
    5.3.3. Potential improvements of the procedure
    5.4. PeriAttacher® and AttachGuider®
    5.5. Pericardial access using a blunt-tip needle
    5.6. Transbronchial approach
    5.7. Computer guided pericardiocentesis
    5.8. Pericardiocentesis guided by computed tomography
    5.9. Pericardiocentesis guided by a pacing capture
    5.10. Future perspectives and recommendations
    6. Pericardiocentesis in the Absence of Effusion
    6.1. Introduction
    6.2. Subxiphoid pericardiocentesis using a Tuohy needle and fluoroscopy
    6.2.1. Technique and potential complications
    6.2.2. Feasibility and safety
    6.2.3. Limitations of the approach
    6.3. The PerDUCER® technique
    6.3.1. Experimental experience
    6.3.2. Access of the human pericardium in the absence of effusion using PerDUCER
    6.4. Pericardial access via trans-atrial approach
    6.4.1. Catheter system with a pre-mounted needle
    6.4.2. Streamlined catheter system
    6.4.3. Safety of the transatrial approach
    6.4.4. Study limitations
    6.4.5. Clinical implications
    6.5. Right ventricular approach
    6.6. Future perspectives and recommendations
    7. Diagnostic Value of Pericardial Fluid Analyses
    7.1. Introduction
    7.2. Volume and appearance of pericardial effusion
    7.3. Pericardial fluid cytology
    7.3.1. Number of specimens needed for pericardial fluid cytology
    7.3.2. Detection of malignancy by pericardial fluid cytology
    7.3.3. Reactive mesothelial vs. adenocarcinoma cells
    7.3.4. Prognostic and therapeutic implications
    7.3.5. Paramalignant pericardial effusion
    7.3.6. Blood cells in pericardial effusion
    7.3.7. Staining for bacteria in pericardial effusion
    7.4. Biochemical analyses
    7.4.1. Differentiation of transudates and exudates
    7.4.2. Pericardial cytokines
    7.4.3. Adenosine deaminase activity in pericardial effusion
    7.5. Virology of pericardial effusion
    7.5.1. Polymerase chain reaction – PCR
    7.6. Bacteriology of pericardial effusion
    7.6.1. Bacteriology of pericardial effusion in tuberculous pericarditis
    7.6.2. Bacteriology of pericardial effusion in patients with AIDS
    7.7. Tumor markers
    7.7.1. Carcinoembryonic antigen – CEA
    7.7.2. Neuron-specific enolase – NSE
    7.7.3. Carbohydrate antigen 125 – CA125
    7.7.4. Alpha-fetoprotein
    7.8. Immunology of pericardial effusion
    7.8.1. Serodiagnosis of tuberculous pericarditis
    7.9. Future perspectives and recommendations
    8. Pericardioscopy: Endoscopic Insight into Pericardial Pathology
    8.1. Introduction
    8.2. Technical considerations
    8.3. Analysis of diagnostic value
    8.4. Feasibility and safety
    8.5. Future perspectives and recommendations
    9. Epicardial and Pericardial Biopsy
    9.1. Introduction
    9.2. Technique
    9.2.1. Pericardial biopsy guided by fluoroscopy
    9.2.2. Pericardial and epicardial biopsy targeted by pericardioscopy
    9.3. Sampling efficiency and histological findings
    9.4. Sensitivity of pericardial biopsy:
    a key issue for the successful clinical application
    9.5. Diagnostic value
    9.6. The analyses of the epicardial and pericardial biopsy samples
    9.6.1. Processing techniques
    9.6.2. Molecular biology techniques
    9.6.3. Immunohistochemistry of epicardial biopsies
    9.7. Safety and complications
    9.8. Future perspectives and recommendations
    10. Intrapericardial Treatment of Pericardial Disease
    10.1. Introduction
    10.2. Intrapericardial treatment of neoplastic pericarditis
    10.2.1. Cisplatin
    10.2.2. Thiotepa
    10.2.3. Alternative agents
    10.3. Intrapericardial treatment of autoreactive pericarditis
    10.4. Intrapericardial treatment of uremic pericarditis
    10.5. Intrapericardial treatment of purulent pericarditis
    10.6. Future perspectives and recommendations
    11. Percutaneous Balloon Pericardiotomy
    11.1. Introduction
    11.2. Indications and contraindications
    11.3. Methodological considerations
    11.4. Mechanism of action
    11.5. Balloon catheter selection
    11.6. Multicenter analysis of feasibility and long-term results
    11.7. Safety
    11.8. Future perspectives and recommendations
    12. Frontiers and Emerging Procedures
    12.1. Introduction
    12.2. Intrapericardial echocardiography
    12.3. Intrapericardial treatment of non-pericardial diseases
    12.3.1. Potential advantages of intrapericardial approach
    12.3.2. Possible drawbacks of intrapericardial pharmacokinetics
    12.3.3. Intrapericardial application of coronary vasodilators
    12.3.4. Intrapericardial anti-arrhythmic therapy
    12.3.5. Intrapericardial prevention of restenosis
    12.3.6. Intrapericardial gene therapy
    12.3.7. Intrapericardial application of growth factors
    12.3.8. Intrapericardial application of stem cells
    12.3.9. Intrapericardial treatment of ventricular rupture
    12.4. Ambulatory pericardial drainage using a permanent port system
    12.5. The Heart-Lander® – intrapericardial crawling robotic device
    12.6. Epicardial mapping and radiofrequent ablation
    12.7. Future perspectives and recommendations
    INDEX